Shows / Lung Cancer Considered
Lung Cancer Considered
Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide…
The show, from its episodes
No episode notes yet. Recurring topics, people and starter picks will appear when notes are available.
Typical episode length
39m · median of 425 episodes with a known length
Solo / guest format
Unknown — existing notes name people mentioned, but do not identify hosts or guests.
Recurring topics
No recurring topics established yet.
Recurring people
No recurring people established yet.
Start here
No starter picks yet — no published episodes with audio and a recorded notes hook.
Episodes
Lung Cancer ConsideredLung Cancer Considered--Hungarian Episode
In this special episode of Lung Cancer Considered recorded in Hungarian, lung cancer experts in Hungary and the United States discuss challenges and emerging…
Lung Cancer ConsideredIASLC - Mesothelioma
Mesothelioma is a particularly challenging cancer to treat and there had been relatively few updates in its management until the recent integration of…
Lung Cancer ConsideredNACLC 2023 Preview
In this episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu preview the 2023 North America Conference on Lung Cancer, scheduled for…
Lung Cancer ConsideredWCLC 2023 - Meeting Wrap Up
Lung Cancer Considered Hosts Dr. Narjust Florez and Dr. Stephen Liu wrap up WCLC 2023 in Singapore, discussing the meeting's most impactful research, including…
Lung Cancer ConsideredWCLC 2023 - Tuesday Highlights
Lung Cancer Considered hosts Dr. Narjust Florez and Dr. Stephen Liu recap three important sessions from Tuesday, September 12th at the IASLC WCLC 2023…
Lung Cancer ConsideredMARS 2 in Spanish--Monday WCLC Highlights
MARS 2 in Spanish--Monday WCLC Highlights In this Spanish-language podcast, Lung Cancer Considered Host Dr. Narjust Florez enlists two colleagues to discuss…
Lung Cancer ConsideredLive from WCLC: Monday Highlights
Monday at WCLC 2023 features the Presidential Symposium. In this special WCLC 2023 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen…
Lung Cancer ConsideredLive from WCLC: Sunday Highlights
Sunday highlights from WCLC 2023 include hosts Dr. Narjust Florez and Dr. Stephen Liu discussing two-year data from KRYSTAL-1 with Dr. Shirish Gadgeel; a…
Lung Cancer ConsideredTitle: Gender Equity and Beyond, a discussion with HRH Princess Dina Mired of Jordan
From lung cancer in women to gender equity in the healthcare workforce, IASLC is privileged to host HRH Princess Dina Mired of Jordan at the 2023 World…
Lung Cancer ConsideredIASLC Lung Cancer Considered Drug Development and Targeted Therapies
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses targeted therapies, what they are, and how they have changed our approach to treating…
Lung Cancer ConsideredI want to be an oncologist: Where to start?
In this epidose of Lung Cancer Considered, Dr. Narjust Florez leads a discussion on the journey to an oncology fellowship. Medical training is long, full of…
Lung Cancer ConsideredLung Cancer Care in Mandarin: EGFR in China - From Testing to Treating
Lung Cancer Care in Mandarin: EGFR in China - From Testing to Treating by IASLC
Lung Cancer ConsideredArtificial Intelligence And Lung Cancer
Artificial intelligence is one of the most significant trends in most parts of society. Increasingly, oncologists and lung cancer researchers are including AI…
Lung Cancer ConsideredLCC in Greek: Treating Lung Cancer in Greece
Greece ranks third in mortality in Europe from lung cancer, surpassed by Hungary and Serbia. In this episode of Lung Cancer Considered, host Dr. Giannis…
Lung Cancer ConsideredIASLC Hot Topic in Basic and Translational Science Meeting Preview
This episode of Lung Cancer Considered previews the upcoming IASLC Hot Topic in Basic and Translational Science Meeting on Resistance to Immunotherapy in…
Lung Cancer ConsideredUpdated IASLC - Virtual Tumor Board On SCLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the management of small-cell lung cancer using a virtual tumor board format. SCLC is…
Lung Cancer ConsiderediMig Meeting Highlights
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discuss some of the highlights from iMig 2023 – the meeting of the International Mesothelioma…
Lung Cancer ConsideredIASLC - EGFR NSCLC In Brazil
This episode of Lung Cancer Considered examines the treatment of EGFR-positive lung cancer in Brazil from early-stage disease to metastatic lung cancer…
Lung Cancer ConsideredEvolving Role of Liquid Biopsy for Lung Cancer
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion with two global experts about the current and future roles of liquid biopsy…
Lung Cancer ConsideredIASLC - ASCO 2023 Highlights
In this episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu lead a discussion on the recently completed ASCO 2023 meeting that…
Lung Cancer ConsideredWCLC 2023 Preview: Singapore
WCLC 2023 is a global, multi-disciplinary meeting designed for physicians, nurses, clinicians, researchers, scientists, survivors and advocates. This year, the…
Lung Cancer ConsideredLCC in Polish: Overcoming Barriers to Lung Cancer Therapy in Poland
LCC in Polish: Overcoming Barriers to Lung Cancer Therapy in Poland This special Polish-language episode of Lung Cancer Considered focuses on the unique…
Lung Cancer ConsideredLung Cancer Considered: Decoding ROS1 Fusions in Lung Cancer
In this episode of Lung Cancer Considered, host Dr. Narjust Florez discusses ROS+1 Fusions in NSCLC, including diagnosis, treatment and new exciting research…
Lung Cancer ConsideredSCLC Transformation in EGFR NSCLC
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion on EGFR NSCLC and transformation to small cell lung cancer, a relatively…
Lung Cancer ConsideredUpdated IASLC - ADAURA
Lung Cancer Considered hosts Dr. Narjust Flores and Dr. Stephen Liu talk with Dr. Roy Herbst about the ADAURA Trial. ADAURA introduced targeted therapy in the…
Lung Cancer ConsideredIASLC - Meeting the New JTO CRR Editor in Chief
In this episode of Lung Cancer Considered, host Dr. Narjust Florez interviews Dr. Emily Stone, the new editor of JTO Clinical and Research Reports. The podcast…
Lung Cancer ConsideredIASLC - French Language Podcast
Host Dr. Alfredo Addeo, Senior Oncologist, Geneva University Hospital, in Geneva, Switzerland moderates a special French-language episode of Lung Cancer…
Lung Cancer ConsideredIASLC - ELCC 2023 Highlights
This episode of Lung Cancer Considered covers the recently completed European Lung Cancer Congress held in Copenhagen. Host Dr. Stephen Liu, Dr. Heather…
Lung Cancer ConsideredIASLC - EGFR Mutant NSCLC Post Osimertinib
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a new Virtual Tumor Board on EGFR mutant NSCLC and acquired resistance. Dr. Liu is joined…
Lung Cancer ConsideredIASLC - LCC in Italian: Updates in Resectable NSCLC
IASLC - LCC in Italian: Updates in Resectable NSCLC by IASLC
Lung Cancer ConsideredIASLC - SCLC 2023 Meeting Preview
In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a conversation about small cell lung cancer and previews the upcoming IASLC 2023 Hot…
Lung Cancer ConsideredIASLC The Great Debate Dr. Einhorn Dr. Simone And Dr. Florez
In this episode of Lung Cancer Considered, recorded at the 2023 Targeted Therapies of Lung Cancer meeting, host Dr. Narjust Florez moderates a conversation…
Lung Cancer ConsideredLCC Targeted Therapy Recap
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a recap of the recent IASLC meeting, Targeted Therapies for Lung Cancer, or TTLC23 --a…
Lung Cancer ConsideredIASLC - Neoadjuvant
In this Virtual Tumor Board episode of Lung Cancer Considered, host Dr. Stephen Liu and his guests discuss the dynamic topic of managing resectable stage III…
Lung Cancer ConsideredIASLC EGFR AM And PM
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on a specific subset of lung cancer: EGFR exon 20 insertion NSCLC. Joining…
Lung Cancer ConsideredIASLC RET NSCLC
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion about NSCLC with RET rearrangements, including diagnosis, treatment, and…
Lung Cancer ConsideredIASLC - KRAS G12C
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a conversation on KRAS G12C mutation. Joining the podcast are Dr. Melissa Johnson, the…
Lung Cancer ConsideredIASLC - LALCA Highlights
The Latin American Conference on Lung Cancer, held in Uruguay, wrapped up in late January. To provide a summary of key findings from the meeting, Lung Cancer…
Lung Cancer ConsideredIASLC FDA Approval Adjuvant Pembrolizumab For NSCLC
On January 26, 2023, the US FDA granted approval of pembrolizumab, an anti-PD-1 antibody, as an adjuvant therapy for patients with resected NSCLC. In this…
Lung Cancer ConsideredIASLC IPASS Study 2
In this special episode of Lung Cancer Considered, hosts Dr. Stephen Liu and Dr. Narjust Florez discuss the seminal IPASS trial with its principal…
Lung Cancer ConsideredLung Cancer In Brazil with Clarissa Maria Cerqueira, Mathias Ticiana Leal And Carlos G. Ferreira
In a special episode of Lung Cancer Considered focusing on lung cancer in Brazil, host Dr. Clarissa Mathias, medical oncologist at Oncoclinicas Bahia and…
Lung Cancer ConsideredPatient Advocacy Groups with Janet Freeman-Daily, Seamus Cotter & Terri Conneran
Host Dr. Narjust Florez engages with three leading lung cancer patient advocates on the importance of patient advocacy groups, how these were formed…
Lung Cancer ConsideredRadon with Hina Khan And Laura Mezquita
Radon exposure is a known risk factor for lung cancer yet it does not garner as much attention as other risk factors. In this episode of Lung Cancer…
Lung Cancer ConsideredRadiology - Management of Lung Cancer with Florian Fintelmann and Carole Ridge
Radiologists play central roles in the detection of lung cancer, in assessing response to therapy and relapse of disease and increasingly, interventional…
Lung Cancer ConsideredFDA Approval: Adagrasib with Sheena Bhalla and Joshua Sabari
This week, the FDA granted accelerated approval to Adagrasib to treat advanced NSCLC with a KRAS G12C mutation after at least one prior line of systemic…
Lung Cancer ConsideredLung Cancer in Israel with Alona Zer, Jair Bar and Nir Peled
In this special edition of Lung Cancer Considered, three oncologists and lung cancer experts explore lung cancer in Israel, spoken in Hebrew. Host Dr. Alona…
Lung Cancer ConsideredACLC & ESMO Asia 2022 Highlights
In this episode of Lung Cancer Considered, host Dr. Stephen Liu and invited guests to discuss the IASLC Asian Conference on Lung Cancer (ACLC) held in Japan…
Lung Cancer ConsideredLung Cancer in the Middle East with Nagla Karim, Houssein Abdul Sater, and Abdelrahman Mohamed
In this special edition of Lung Cancer Considered, three oncologists and lung cancer experts explore lung cancer in the Middle East (North Africa), spoken in…
Lung Cancer ConsideredMET In NSCLC with Noemi Reguart and Ross Camidge
This episode of Lung Cancer Considered covers a subset of patients with non-small cell lung cancer with lung cancer -- MET exon 14 skipping mutations. MET exon…
Lung Cancer ConsideredEMPOWER-Lung 3 with Jordi Remon and Isabel Preeshagul
This episode of Lung Cancer Considered is part of our series on FDA approvals of new lung cancer therapies. Today, host Dr. Stephen Liu discusses the…
Lung Cancer ConsideredThe POSEIDON Trial With Tejas Patil
Dr. Narjust Florez discusses the POSEIDON trial with guest Dr. Tejas Patil, assistant professor at Thoracic Oncology Research Initiative, University of…
Lung Cancer ConsideredClimate Change & Lung Cancer, Part 2 with Christine Berg And Roselle De Guzman
There has been a steady stream of research presented that ties air pollution to an increased risk for lung cancer. To discuss this trend, Lung Cancer…
Lung Cancer ConsideredEvolution Of Stage III NSCLC with Martin Reck and Paula Antonia Ugalde Figueroa
In this episode of Lung Cancer Considered, host Dr. Stephen Liu, Director of Thoracic Oncology at Georgetown University, leads a discussion about the…
Lung Cancer ConsideredSeminal Trial Series: ECOG 1594
At the time it was published in the New England Journal of Medicine in 2002, ECOG 1594 was the first study to compare whether any of the three chemotherapy…
Lung Cancer ConsideredLung Cancer Care In Rural US With Debora Bruno And Gabrielle Rocque
Lung cancer research is often centered at large, urban academic medical centers. But what research and treatment options are available for those patients with…
Lung Cancer ConsideredLung Cancer in China - Mandarin
In this special edition of Lung Cancer Considered, three esteemed oncologists and lung cancer experts explore the issues facing the medical profession in…
Lung Cancer ConsideredLung Cancer in Japan with Misako Nagasaka, Tetsuya Mitsudomi and Takashi Seto
In keeping with its mission to cover lung cancer from a global perspective, this episode of Lung Cancer Considered focuses on lung cancer in Japan. Host Dr…
Lung Cancer ConsideredLiquid Biopsy with David Gandara, Charu Aggarwal and Christian Rolfo
Over the past few years, the use of liquid biopsy has improved the ability to detect biomarkers for non-small cell lung cancer. In this episode of Lung Cancer…
Lung Cancer ConsideredInterventional Pulmonary with Rebecca Krochmal and Daniel Sterman
In this episode of Lung Cancer Considered, host Dr. Narjust Florez talks about the critical role interventional pulmonologists play on the cancer care team…
Lung Cancer ConsideredESMO 2022 Highlights
Did you miss ESMO this year? Listen to Lung Cancer Considered host and thoracic oncologist Dr. Narjust Florez discuss the key highlights involving science and…